Skip to Content

Welcome to:

The In Vivo Imaging Community







home
Image Map

►Click on spheres for additional info

The In Vivo Imaging Page provides a Discussion Forum and Links to information about the discipline of "In Vivo" Molecular Imaging with an emphasis on Pre-clinical Animal Models, not excluding Translational Imaging. Techniques covered are: Optical Imaging, Molecular Imaging, Fluorescence Imaging, Bioluminescence Imaging, MRI, PET, SPECT, CT, Ultrasound and Intravital Microscopy.

Sign Up to access full Resources.

 


 

 


 

IN VIVO IMAGING - WHITE PAPERS

Cell Transfection is no longer your Roadblock to Publication.

Cell Transfection allows researchers to manipulate gene expression in cells. In order to evaluate physiological or pathological processes, your specific protein of interest can be expressed, or depleted by means of cell transfection. Furthermore, the new field of molecular imaging allows visualization of molecular mechanisms of disease in real time, non-invasively with reporter genes. New, flexible methodology makes Cell Transfection affordable and easy. Read more


Luciferases and in vivo molecular imaging.

Multiple luciferases have been cloned and applications in molecular biology and in vivo optical imaging have been identified. This review focuses on features of luciferases and their correspondent substrates called luciferins, commonly used in in vivo molecular imaging. Luciferases and bioluminescence imaging offer a significant advantage... Read more

 

RNA interference (RNAi) imaging.

Molecular imaging of gene function by means of RNA interference (RNAi) is powerful, real time  methodology. Targeted RNAi gene knockdown is a highly efficient technique technique in comparison to traditional gene knockout technology, facilitating the study of functional genomics in vitro in cell lines as well as in vivo in live animals. Vector co-expression of RNAi with GFP or firefly luciferase (Luc2) serves as a marker for infectivity and allows tracking and imaging of the RNAi knockdown cells in real time.  siRNA lentiviral expression methodology is described. Read more

 

How to use a Lentivirus as a vehicle for reporter gene transfection of cells.

Lentivirus protocol to make your own luciferase cell lines, Fast and easy.

Labeling cells with a genetically encoded reporter gene (firefly luciferase, red fluorescent protein, transferrin, thymidine kinase, etc.) is the number one choice for in vivo molecular imaging. Various transfection protocols to introduce foreign DNA in cells exist. A virus is nature’s own shuttle of genetic material and therefore viral infection is by far the most efficient transduction method even for resilient cell lines. A lentivirus Read more

 

Are you new to in vivo imaging?

An in vivo imaging modalities overview

In vivo imaging in laboratory animals is a relatively new methodology that is gaining fast acceptance in biomedical research.  Imaging modalities frequently utilized in in vivo research are mostly adaptations from familiar, clinical imaging instrumentation such as X-ray, ultrasound, CT, SPECT, PET and MRI. However, newer technologies such as Optical Imaging and Intravital Microscopy originated with lab animal applications in mind. The diverse choice in imaging platforms available may foster the question of which modality is the best fit for your research model. Read more

 

Imaging tumor perfusion with Contrast Ultrasound.

Response to therapy assessment.

Microbubble ultrasound contrast agents have been used for qualitative assessment of solid lesions in a clinical setting for several years. Recent work has described the use of these agents for measurement of the tumor vasculature, primarily as a quantitative endpoint for monitoring patient response to anti-cancer therapy. The size of the microbubble agent (1-8 um) renders them purely intravascular flow tracers, and early work confirmed that the kinetics of these agents in the blood are similar to that of erythrocytes Read more

 

In Vivo Optical Imaging Reporters.

There is a plethora of choice in reporter tags for non-invasive in vivo optical imaging (fluorescence and bioluminescence) that are currently available from various commercial suppliers. This generates tremendous flexibility on one hand, but dilemma of choice on the other. This manuscript reviews the determining factors and will facilitate decision making using an interactive flow chart. Read more

 

D-Luciferin: in vivo imaging methods.

D-luciferin [(S)-2-(6′-hydroxy-2′-benzothiazolyl)thiazoline-4-carboxylic acid] is the substrate of the North American firefly Photinus Pyralis luciferase and Clickbeetle Red and Clickbeetle Green luciferase. Luciferin is a low molecular weight (318.41 g/mole) organic compound that consists of a benzothiazole moiety attached to a thiazole carboxylic acid moiety. Luciferin is a small molecule which freely diffuses across membranes. When luciferin is injected in vivo Read more

 

Cell Culture Techniques for In Vivo Grafting.

Mouse models for in vivo imaging of cancer established by in vivo grafting of syngeneic or xenogeneic cells in recipient animals are commonly practiced. Success of these studies relies upon solid cell culture technique. This article covers sterile technique, thawing and freezing, subculture and preparation of cells for grafting. Read more
 

Microbubbles for in vivo ultrasound mouse imaging are encapsulated, inert gas filled colloidal particles. Upon intravenous injection, they are used as ultrasound contrast agents. Read more

 

Inhalation Anesthesia for in vivo molecular imaging.

Inhalation anesthesia with isoflurane is quickly becoming the standard method of general anesthesia for rats and mice used in biomedical research and is imperative for in vivo imaging. Inhalation anesthetics, breathing circuits, gas scavenging systems and oxygen flow rate are discussed.  Read more

 

Lab Animal Anesthesia - inhalation and injectable protocols.

Instrumentation and methods for gas anesthesia and dosing for injectable anesthetics such as xylazine/ketamine and avertin are described. Read more

 

 

MICAD DATABASE - NEW AGENTS

PET Agents

[11C]P-gp-6 Target: P-glycoprotein multidrug transporter
[11C]MC-266 Target: P-glycoprotein multidrug transporter
[11C]PZA Target: Type 1 fatty acid synthases
[11C]INH Target:  Synthesis of mycolic acid
[11C]CHIBA-1001 Target: Neuronal α7 nicotinic acetylcholine receptor (nAChR)
[11C]MePPEP Target: Cannabinoid CB1 receptors
[11C]FMePPEP Target: Cannabinoid CB1 receptors
[18F]FEPEP Target: Cannabinoid CB1 receptors
[18F]FMPEP-d2 Target: Cannabinoid CB1 receptors
[18F]FMPEP Target: Cannabinoid CB1 receptors
[18F]FEP-4MA Target: Acetylcholinesterase (AChE)
4-[18F]Fluorobenzoyl-knottin 2.5D Target: αvβ3, αvβ5, and α5β1 integrins
[18F]HX4 Target: Hypoxic tissue
[18F]4V  Target: Vascular cell adhesion molecule-1 (VCAM-1)
 64Cu-DOTA-Panitumumab Target: Epidermal growth factor receptor (EGFR, HER1)
[89Zr]-cG250-F(ab')2 Target: Carbonic anhydrase IX (G250)
 

SPECT Agents

99mTc-LACTAL Target: Asialoglycoprotein receptors (ASGP-Rs)
 

MRI Agents

YCC-DOX Target: Folate receptor
 

Multimodality Agents

[166Ho]-PLLA-MS Target: Hepatic arterioles

 

RECENT IN VIVO IMAGING PUBLICATIONS

Powered by Drupal, an open source content management system